| 1 |
33850273 | P300/CBP inhibition sensitizes mantle cell lymphoma to PI3Kδ inhibitor idelalisib. | 2022 Feb |
2 |
| 2 |
33704060 | Promoter-specific changes in initiation, elongation, and homeostasis of histone H3 acetylation during CBP/p300 inhibition. | 2021 Mar 11 |
1 |
| 3 |
34199844 | Pharmacological Inhibition of CBP/p300 Blocks Estrogen Receptor Alpha (ERα) Function through Suppressing Enhancer H3K27 Acetylation in Luminal Breast Cancer. | 2021 Jun 4 |
1 |
| 4 |
34801827 | Design, synthesis and biological evaluation of a novel spiro oxazolidinedione as potent p300/CBP HAT inhibitor for the treatment of ovarian cancer. | 2021 Dec 15 |
1 |
| 5 |
28953875 | Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours. | 2017 Oct 5 |
1 |